Items where authors include "Teerawattananon, Yot"

Article

Botwright, Siobhan, Munira, Syarifah Liza, Megiddo, Itamar orcid.org/0000-0001-8391-6660 et al. (4 more authors) (2026) Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings. Pharmacoeconomics. ISSN 1179-2027

Ochalek, Jessica M. orcid.org/0000-0003-0744-1178, Woods, Beth orcid.org/0000-0002-7669-9415, Pongcharoenyong, Lapad et al. (5 more authors) (2026) Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients in the Thai healthcare system. Value in Health. pp. 632-640. ISSN 1524-4733

Botwright, Siobhan, Yongphiphatwong, Natcha, Teerawattananon, Yot et al. (6 more authors) (2026) A case study integrating scenario thinking with dialysis policymaking in Thailand. Communications medicine. 44. ISSN 2730-664X

Botwright, Siobhan, Teerawattananon, Yot, Phannajit, Jeerath et al. (6 more authors) (2025) Balancing patient choice and health system capacity: a system dynamics model of dialysis in Thailand. BMC Medicine. 646. ISSN 1741-7015

Butani, Dimple, Faradiba, Dian, Dabak, Saudamini Vishwanath et al. (6 more authors) (2023) Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations. Journal of Pharmaceutical Policy and Practice. 138. ISSN 2052-3211

Turner, Hugo C, Hori, Yoshiaki, Revill, Paul orcid.org/0000-0001-8632-0600 et al. (5 more authors) (2023) Analyses of the return on investment of public health interventions: a scoping review and recommendations for future studies. BMJ Global health. e012798. ISSN 2059-7908

Oortwijn, Wika, Husereau, Don, Barasa, Edwine et al. (10 more authors) (2022) Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force: A Good Practices Report of a Joint HTAi/ISPOR Task Force. International Journal of Technology Assessment in Health Care. e37. ISSN 0266-4623

Chi, Y-Ling, Blecher, Mark, Chalkidou, Kalipso et al. (16 more authors) (2020) What next after GDP-based cost-effectiveness thresholds? [version 1; peer review: 2 approved]. Gates open research. 176. ISSN 2572-4754

Isaranuwatchai, Wanrudee, Teerawattananon, Yot, Archer, Rachel A. et al. (16 more authors) (2020) Prevention of non-communicable disease: Best buys, wasted buys, and contestable buys. The BMJ. m141. ISSN 1756-1833

Emerson, Joanna, Panzer, Ari, Cohen, Joshua T. et al. (6 more authors) (2019) Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS ONE. e0205633. ISSN 1932-6203

Chalkidou, K., Culyer, Anthony J, Glassman, Amanda et al. (2 more authors) (2017) Health Technology Assessment: global advocacy and local realities: comment on ‘Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness. International Journal of Health Policy and Management. pp. 233-236. ISSN 2322-5939

Wilkinson, Thomas, Sculpher, Mark J orcid.org/0000-0003-3746-9913, Claxton, Karl orcid.org/0000-0003-2002-4694 et al. (8 more authors) (2016) The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought. Value in Health. pp. 921-928. ISSN 1524-4733